Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ATRA

Atara Biotherapeutics, Inc.

CIK 0001604464 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$9.76
↓ 0.19 (-1.86%)
as of Jul 10, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$89.61M
P/E Ratio
-9.47
EPS
2.61
Dividend Yield
Not covered
52W Position
38%
Beta
1.37

Valuation multiples

Fwd P/E
3.63
PEG
0.00
P/B
-2.40
P/S
3.87
EV/Revenue
3.51
ROE
25.4%
Valuation data covers 8,503/9,464 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 38%
$3.92$19.14

Latest Financials

2025-12-31 FY
Revenue
$120.77M
Net Income
$32.69M
Total Assets
$20.23M
Free Cash Flow
-$50.94M

Recent news